Market Overview:
The global creatine kinase reagent market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising demand for point-of-care testing, and growing awareness about early diagnosis and treatment of various diseases. Based on type, the global creatine kinase reagent market is segmented into R1 5*20 ml; R2 1*25 ml, R1 5*80 ml; R2 1*100 ml, R1 1*800 ml; R2 1*200 ml, and others. Based on application, the global creatine kinase reagent market is segmented into hospitals, clinics, diagnostic laboratories,, academic research institutes,, and others. Geographically speaking,, North America dominates the global creatine kinase reagent market followed by Europe., Asia Pacific is projected to be the fastest growing region duringthe forecast period owingto rising healthcare expenditureand improving healthcare infrastructure in countries such as Chinaand India., Latin America holds a significant share of thismarket due tobenefits offered by private playersin terms offree health checkups for employees.
Product Definition:
Creatine kinase reagent is an enzyme that catalyzes the conversion of creatine and adenosine triphosphate (ATP) to phosphocreatine and adenosine diphosphate (ADP). This reaction is important in providing energy for muscle contraction.
R1 5*20 ml; R2 1*25 ml:
R1 5*20 ml; R2 1*25 ml is used for measuring Creatine Kinase (CK) in samples. CK is a phosphorylated form of the enzyme creatine kinase and its measurement provides information about the health of a patient. It's important to measure this biomarker as it gives an early signal for oncological diseases, muscle damage or tissue injury, among others.
R1 5*80 ml; R2 1*100 ml:
R1 5*80 ml; R2 1*100 ml is a clear, colorless solution of creatine kinase. It is used as an electrolyte in the detection of muscle injury during medical examination and treatment. Creatine kinase reagent also called CK-MB or R1 test is used to detect myocardial infarction (heart attack) and stroke by measuring the amount of CK-MB enzyme activity present in the blood sample.
Application Insights:
The academic research institutes application segment held the largest share of the global market in 2017. This is due to rising number of R&D activities pertaining to sports nutrition, which require CK-MB and/or CK-AAA enzyme-based tests for evaluating patient¢â‚¬â„¢s health. Moreover, growing government support towards improving healthcare facilities in underdeveloped and developing countries will boost product demand in this segment over the forecast period.
The hospitals segment is expected to witness lucrative growth over the forecast period owing to increasing incidence of sports injuries and diseases across all regions coupled with a rise in number of surgeries related to musculoskeletal disorders. For instance, according these statistics reported by International Health Systems Inc.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure, and high awareness levels coupled with increasing government initiatives for maintaining health are some factors responsible for its large share. For instance, as per the American College of Medical Genetics (ACMG), in 2016 ACMG launched a collaborative initiative to promote and distribute free creatine kinase reagents to laboratories throughout the U.S., which is further supported by financial assistance program known as ACMG Special Access Program (ACGSC).
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising disposable income leading towards increased demand for medical testing services along with growing target disease population base especially in countries such as India & China & Japan etc. Moreover, increasing number of clinical research studies being conducted will drive growth over this period.
Growth Factors:
- Increasing demand for creatine kinase reagent in the pharmaceutical and biotechnology industries for drug discovery and development processes.
- Growing popularity of creatine kinase reagent as a research tool in academic institutions and research laboratories.
- Rising demand for diagnostic tests that use creatine kinase reagents to detect various diseases and disorders.
- Technological advancements in the field of diagnostics that are helping to increase the adoption of creatine kinase reagents across different applications areas. 5) The increasing prevalence of lifestyle-related diseases such as obesity, diabetes, and heart disease is fueling the growth of the global market for creatine kinase reagents
Scope Of The Report
Report Attributes
Report Details
Report Title
Creatine Kinase Reagent Market Research Report
By Type
R1 5*20 ml; R2 1*25 ml, R1 5*80 ml; R2 1*100 ml, R1 1*800 ml; R2 1*200 ml, Others
By Application
Hospitals, Clinics, Diagnostic Laboratories, Academic Research Institutes, Others
By Companies
Abbott, DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., Tosoh India Pvt. Ltd, BBI Solutions, Pointe Scientific, Inc., PerkinElmer Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
162
Number of Tables & Figures
114
Customization Available
Yes, the report can be customized as per your need.
Global Creatine Kinase Reagent Market Report Segments:
The global Creatine Kinase Reagent market is segmented on the basis of:
Types
R1 5*20 ml; R2 1*25 ml, R1 5*80 ml; R2 1*100 ml, R1 1*800 ml; R2 1*200 ml, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Diagnostic Laboratories, Academic Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- DiaSys Diagnostic Systems GmbH
- Randox Laboratories Ltd.
- Tosoh India Pvt. Ltd
- BBI Solutions
- Pointe Scientific, Inc.
- PerkinElmer Inc.
Highlights of The Creatine Kinase Reagent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- R1 5*20 ml; R2 1*25 ml
- R1 5*80 ml; R2 1*100 ml
- R1 1*800 ml; R2 1*200 ml
- Others
- By Application:
- Hospitals
- Clinics
- Diagnostic Laboratories
- Academic Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Creatine Kinase Reagent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Creatine kinase (CK) is an enzyme that helps to transfer energy from the ATP molecule to other molecules in the body. CK is most commonly found in muscle cells, where it helps to create energy during short-term muscular activity.
Some of the major companies in the creatine kinase reagent market are Abbott, DiaSys Diagnostic Systems GmbH, Randox Laboratories Ltd., Tosoh India Pvt. Ltd, BBI Solutions, Pointe Scientific, Inc., PerkinElmer Inc..
The creatine kinase reagent market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Creatine Kinase Reagent Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Creatine Kinase Reagent Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Creatine Kinase Reagent Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Creatine Kinase Reagent Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Creatine Kinase Reagent Market Size & Forecast, 2020-2028
4.5.1 Creatine Kinase Reagent Market Size and Y-o-Y Growth
4.5.2 Creatine Kinase Reagent Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 R1 5*20 ml; R2 1*25 ml
5.2.2 R1 5*80 ml; R2 1*100 ml
5.2.3 R1 1*800 ml; R2 1*200 ml
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Diagnostic Laboratories
6.2.4 Academic Research Institutes
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Creatine Kinase Reagent Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Creatine Kinase Reagent Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 R1 5*20 ml; R2 1*25 ml
9.6.2 R1 5*80 ml; R2 1*100 ml
9.6.3 R1 1*800 ml; R2 1*200 ml
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Diagnostic Laboratories
9.10.4 Academic Research Institutes
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 R1 5*20 ml; R2 1*25 ml
10.6.2 R1 5*80 ml; R2 1*100 ml
10.6.3 R1 1*800 ml; R2 1*200 ml
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Diagnostic Laboratories
10.10.4 Academic Research Institutes
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 R1 5*20 ml; R2 1*25 ml
11.6.2 R1 5*80 ml; R2 1*100 ml
11.6.3 R1 1*800 ml; R2 1*200 ml
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Diagnostic Laboratories
11.10.4 Academic Research Institutes
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 R1 5*20 ml; R2 1*25 ml
12.6.2 R1 5*80 ml; R2 1*100 ml
12.6.3 R1 1*800 ml; R2 1*200 ml
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Diagnostic Laboratories
12.10.4 Academic Research Institutes
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 R1 5*20 ml; R2 1*25 ml
13.6.2 R1 5*80 ml; R2 1*100 ml
13.6.3 R1 1*800 ml; R2 1*200 ml
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Diagnostic Laboratories
13.10.4 Academic Research Institutes
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Creatine Kinase Reagent Market: Competitive Dashboard
14.2 Global Creatine Kinase Reagent Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 DiaSys Diagnostic Systems GmbH
14.3.3 Randox Laboratories Ltd.
14.3.4 Tosoh India Pvt. Ltd
14.3.5 BBI Solutions
14.3.6 Pointe Scientific, Inc.
14.3.7 PerkinElmer Inc.
